Wang Deping, academician of Ukrainian National Academy of Engineering, and Zhang Boqing, chairman of Beloni Group A delegation visited Shenzhen Cell Valley
On December 6th, Prof. Wang Deping, former director of Biotechnology Development Center of the Ministry of Science and Technology, academician of Ukraine National Academy of Engineering, Chairman Zhang Boqing of Beloni Group and Vice President Zhang Lei of Beloni Group visited Shenzhen Cell Valley. Professor Shi Yuanyuan, chairman of our company, Commercial Director Wei Zheng, and Office Director Wang Lu warmly received us. This visit focuses on the future cell industry policy, aiming to deepen the strategic cooperation relationship and jointly promote the innovative development of the cell industry through the strong alliance between the two sides.
Under the detailed guidance of Commercial Director Wei Zheng, Academician Wang and his delegation visited the Shenzhen Cell Valley Intelligent Digital Exhibition hall, as well as the production and quality management laboratory and RESEARCH and development center, and gained a deeper and deeper understanding and comprehensive understanding of the comprehensive and one-stop service system provided by Shenzhen Cell Valley.
At the symposium, Professor Shi Yuanyuan introduced in detail the leading position and market prospect of Shenzhen Cell Valley in cell therapy technology. He said that relying on its core competitiveness such as industrial production technology, Shenzhen Cell Valley has provided high-standard and safe cell preparation services for many third-class A hospitals in China. At the same time, Cell Valley has not only continuously deepened its layout in the domestic market, but also successfully expanded its business to the overseas market, achieving a key breakthrough in the regional market. Shenzhen Cell Valley has always been adhering to the mission value of "cells benefit all living beings and genes create the future", and is committed to transforming cell therapy technology from basic scientific research to practical clinical application, and bringing innovative therapeutic solutions to patients from all over the country.
At the meeting, Academician Wang Deping and Chairman Zhang Boqing mentioned that many cities, including Tianjin, have issued regulations on the promotion of gene and cell industries, covering the whole industrial chain such as cell collection and storage, research and development clinical trials, expanded use, clinical trials, application and production. The government actively guides leading enterprises to strengthen medical institutions and scientific research institutions through capital injection, technology investment and other ways, to jointly promote the innovative development of gene and cell technologies and products. The purpose of this visit is to explore further cooperation opportunities between the two places under the framework of cell industry policy through an in-depth understanding of the technology and service system of Shenzhen Cell Valley, so as to realize resource sharing and complementary advantages, and jointly promote the high-quality development of cell and gene industry.
At the meeting, Academician Wang Deping and Chairman Zhang Boqing mentioned that many cities, including Tianjin, have issued regulations on the promotion of gene and cell industries, covering the whole industrial chain such as cell collection and storage, research and development clinical trials, expanded use, clinical trials, application and production. The government actively guides leading enterprises to strengthen medical institutions and scientific research institutions through capital injection, technology investment and other ways, to jointly promote the innovative development of gene and cell technologies and products. The purpose of this visit is to explore further cooperation opportunities between the two places under the framework of cell industry policy through an in-depth understanding of the technology and service system of Shenzhen Cell Valley, so as to realize resource sharing and complementary advantages, and jointly promote the high-quality development of cell and gene industry.